Differential expression of toll-like receptor signaling cascades in LPS-tolerant human peripheral blood mononuclear cells

Immunobiology

Volumn 216, Issue 3, 2011, Pages 285-295

  Mendes, Marialice Erdelyi ^a   Baggio Zappia, Giovana Lotici ^a   Brunialti, Milena Karina Coló ^a   Fernandes, Maria da Luz ^a   Rapozo, Marjorie Marini ^a   Salomao, Reinaldo ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gene expression; Innate immunity; LPS; P38; PBMC; Tolerance; Toll like receptors

Indexed keywords

CD14 ANTIGEN; CYCLOOXYGENASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOKINE RESPONSE; DOWN REGULATION; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL TOLERANCE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UPREGULATION;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ADULT; ANTIGENS, CD14; CYCLOOXYGENASE 2; ENDOTOXINS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; INTERLEUKIN-12; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79251599459     PISSN: 01712985     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imbio.2010.07.008     Document Type: Article

References (54)

1. Adib-Conquy M., Adrie C., Fitting C., Gattolliat O., Beyaert R., Cavaillon J.M. Up-regulation of MyD88s and SIGIRR, molecules inhibiting toll-like receptor signaling, in monocytes from septic patients. Crit. Care Med. 2006, 34:2377-2385.
2. Adib-Conquy M., Adrie C., Moine P., Asehnoune K., Fitting C., Pinsky M.R., Dhainaut J.F., Cavaillon J.M. NF-kappaB expression in mononuclear cells of patients with sepsis resembles that observed in lipopolysaccharide tolerance. Am. J. Respir. Crit. Care Med. 2000, 162:1877-1883.
3. Adib-Conquy M., Cavaillon J.M. Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression. J. Biol. Chem. 2002, 277:27927-27934.
4. Adib-Conquy M., Moine P., Asehnoune K., Edouard A., Espevik T., Miyake K., Werts C., Cavaillon J.M. Toll-like receptor-mediated tumor necrosis factor and interleukin-10 production differ during systemic inflammation. Am. J. Respir. Crit. Care Med. 2003, 168:158-164.
5. Alves-Filho J.C., de Freitas A., Spiller F., Souto F.O., Cunha F.Q. The role of neutrophils in severe sepsis. Shock 2008, 1(Suppl. 30):3-9.
6. Beutler B., Hoebe K., Du X., Ulevitch R.J. How we detect microbes and respond to them: the toll-like receptors and their transducers. J. Leukoc. Biol. 2003, 74:479-485.
7. Biswas S.K., Lopez-Collazo E. Endotoxin tolerance: new mechanisms, molecules and clinical significance. Trends Immunol. 2009, 30:475-487.
8. Bohuslav J., Kravchenko V.V., Parry G.C., Erlich J.H., Gerondakis S., Mackman N., Ulevitch R.J. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J. Clin. Invest. 1998, 102:1645-1652.
9. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., Schein R.M., Sibbald W.J. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
10. Brown K.A., Brain S.D., Pearson J.D., Edgeworth J.D., Lewis S.M., Treacher D.F. Neutrophils in development of multiple organ failure in sepsis. Lancet 2006, 368:157-169.
11. Brunialti M.K., Martins P.S., Barbosa de Carvalho H., Machado F.R., Barbosa L.M., Salomao R. TLR2, TLR4, CD14, CD11B, and CD11C expressions on monocytes surface and cytokine production in patients with sepsis, severe sepsis, and septic shock. Shock 2006, 25:351-357.
12. Calvano S.E., Xiao W., Richards D.R., Felciano R.M., Baker H.V., Cho R.J., Chen R.O., Brownstein B.H., Cobb J.P., Tschoeke S.K., Miller-Graziano C., Moldawer L.L., Mindrinos M.N., Davis R.W., Tompkins R.G., Lowry S.F. Inflamm and Host Response to Injury Large Scale Collab Res. Program. A network-based analysis of systemic inflammation in humans. Nature 2005, 437:1032-1037.
13. Cavaillon J.M., Adib-Conquy M. Bench-to-bedside review: endotoxin tolerance as a model of leukocyte reprogramming in sepsis. Crit. Care 2006, 10:233.
14. Chan C., Li L., McCall C.E., Yoza B.K. Endotoxin tolerance disrupts chromatin remodeling and NF-kappaB transactivation at the IL-1beta promoter. J. Immunol. 2005, 175:461-468.
15. Chang M., Jin W., Sun S.C. Peli1 facilitates TRIF-dependent toll-like receptor signaling and proinflammatory cytokine production. Nat. Immunol. 2009, 10:1089-1095.
16. Choudhry M.A., Ahmad S., Ahmed Z., Sayeed M.M. Prostaglandin E2 down-regulation of T cell IL-2 production is independent of IL-10 during gram-negative sepsis. Immunol. Lett. 1999, 67:125-130.
17. del Fresno C., García-Rio F., Gómez-Piña V., Soares-Schanoski A., Fernández-Ruíz I., Jurado T., Kajiji T., Shu C., Marín E., Gutierrez del Arroyo A., Prados C., Arnalich F., Fuentes-Prior P., Biswas S.K., López-Collazo E. Potent phagocytic activity with impaired antigen presentation identifying lipopolysaccharide-tolerant human monocytes: demonstration in isolated monocytes from cystic fibrosis patients. J. Immunol. 2009, 182:6494-6507.
18. Divanovic S., Trompette A., Atabani S.F., Madan R., Golenbock D.T., Visintin A., Finberg R.W., Tarakhovsky A., Vogel S.N., Belkaid Y., Kurt-Jones E.A., Karp C.L. Negative regulation of toll-like receptor 4 signaling by the toll-like receptor homolog RP105. Nat. Immunol. 2005, 6:571-578.
19. Dobrovolskaia M.A., Vogel S.N. Toll receptors CD14, and macrophage activation and deactivation by LPS. Microbes Infect. 2002, 4:903-914.
20. Escoll P., del Fresno C., García L., Vallés G., Lendínez M.J., Arnalich F., López-Collazo E. Rapid up-regulation of IRAK-M expression following a second endotoxin challenge in human monocytes and in monocytes isolated from septic patients. Biochem. Biophys. Res. Commun. 2003, 311:465-472.
21. Fan H., Cook J.A. Molecular mechanisms of endotoxin tolerance. J. Endotoxin Res. 2004, 10:71-84.
22. Foster S.L., Hargreaves D.C., Medzhitov R. Gene-specific control of inflammation by TLR-induced chromatin modifications. Nature 2007, 447:972-978.
23. Frankenberger M., Pechumer H., Ziegler-Heitbrock H.W. Interleukin-10 is upregulated in LPS tolerance. J. Inflamm. 1995, 45:56-63.
24. Frevel M.A., Bakheet T., Silva A.M., Hissong J.G., Khabar K.S., Williams B.R. p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol. Cell. Biol. 2003, 23:425-436.
25. Galanos C., Freudenberg M.A., Katschinski T., Salomao R., Mossmann H., Kumazawa Y. Tumor necrosis factor and host response to endotoxin. Bacterial Endotoxic Lipopolysaccharides 1992, 88-93. CRC Press. J.L. Ryan, D.C. Morrison (Eds.).
26. Galanos C., Freudenberg M.A., Lüderitz O., Rietschel E.T., Westphal O. Chemical, physicochemical and biological properties of bacterial lipopolysaccharides. Prog. Clin. Biol. Res. 1979, 29:321-332.
27. García M.A., Gil J., Ventoso I., Guerra S., Domingo E., Rivas C., Esteban M. Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action. Microbiol. Mol. Biol. Rev. 2006, 70:1032-1060.
28. Gilroy D.W., Colville-Nash P.R., Willis D., Chivers J., Paul-Clark M.J., Willoughby D.A. Inducible cyclooxygenase may have anti-inflammatory properties. Nat. Med. 1999, 5:698-701.
29. Goh K.C., deVeer M.J., Williams B.R. The protein kinase PKR is required for p38 MAPK activation and the innate immune response to bacterial endotoxin. EMBO J. 2000, 19:4292-4297.
30. Härter L., Mica L., Stocker R., Trentz O., Keel M. Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 2004, 22:403-409.
31. Horng T., Barton G.M., Medzhitov R. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2001, 2:835-841.
32. Labeta M.O., Durieux J.J., Spagnoli G., Fernandez N., Wijdenes J., Herrmann R. CD14 and tolerance to lipopolysaccharide: biochemical and functional analysis. Immunology 1993, 80:415-423.
33. Lawrence T., Gilroy D.W., Colville-Nash P.R., Willoughby D.A. Possible new role for NF-kappaB in the resolution of inflammation. Nat. Med. 2001, 7:1291-1297.
34. Maelfait J., Beyaert R. Non-apoptotic functions of caspase-8. Biochem. Pharmacol. 2008, 76:1365-1373.
35. Mages J., Dietrich H., Lang R. A genome-wide analysis of LPS tolerance in macrophages. Immunobiology 2007, 212:723-737.
36. Martins P.S., Brunialti M.K., Martos L.S., Machado F.R., Assunçao M.S., Blecher S., Salomao R. Expression of cell surface receptors and oxidative metabolism modulation in the clinical continuum of sepsis. Crit. Care 2008, 12:25.
37. Medvedev A.E., Henneke P., Schromm A., Lien E., Ingalls R., Fenton M.J., Golenbock D.T., Vogel S.N. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of toll-like receptors 2 or 4. J. Immunol. 2001, 167:2257-2267.
38. Medvedev A.E., Lentschat A., Wahl L.M., Golenbock D.T., Vogel S.N. Dysregulation of LPS-induced toll-like receptor 4-MyD88 complex formation and IL-1 receptor-associated kinase 1 activation in endotoxin-tolerant cells. J. Immunol. 2002, 169:5209-5216.
39. Medvedev A.E., Vogel S. Overexpression of CD14 TLR4, and MD-2 in HEK 293T cells does not prevent induction of in vitro endotoxin tolerance. J. Endotoxin Res. 2003, 9:60-64.
40. Mendez C., Jaffray C., Wong V., Salhab K.F., Kramer A.A., Carey L.C., Norman J.G. Involvement of p38 mitogen-activated protein kinase in the induction of tolerance to hemorrhagic and endotoxic shock. J. Surg. Res. 2000, 91:165-170.
41. Mirlashari M.R., Lyberg T. Expression and involvement of Toll-like receptors (TLR)2 TLR4, and CD14 in monocyte TNF-alpha production induced by lipopolysaccharides from Neisseria meningitidis. Med. Sci. Monit. 2003, 9:316-324.
42. Nahid M.A., Pauley K.M., Satoh M., Chan E.K. miR-146a is critical for endotoxin-induced tolerance: implication in Innate Immunity. J. Biol. Chem. 2009, 284:34590-34599.
43. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 2000, 164:3476-3479.
44. Piao W., Song C., Chen H., Diaz M.A., Wahl L.M., Fitzgerald K.A., Li L., Medvedev A.E. Endotoxin tolerance dysregulates MyD88- and Toll/IL-1R domain-containing adapter inducing IFN-beta-dependent pathways and increases expression of negative regulators of TLR signaling. J. Leukoc. Biol. 2009, 86:863-875.
45. Riedemann N.C., Guo R.F., Ward P.A. Novel strategies for the treatment of sepsis. Nat. Med. 2003, 9:517-524.
46. Rigato O., Salomao R. Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 2003, 19:113-116.
47. Salomao R., Brunialti M.K., Gomes N.E., Mendes M.E., Diaz R.S., Komninakis S., Machado F.R., da Silva I.D., Rigato O. Toll-like receptor pathway signaling is differently regulated in neutrophils and peripheral mononuclear cells of patients with sepsis, severe sepsis, and septic shock. Crit. Care Med. 2009, 37:132-139.
48. Salomao R., Brunialti M.K., Kallás E.G., Martins P.S., Rigato O., Freudenberg M. Lipopolysaccharide-cell interaction and induced cellular activation in whole blood of septic patients. J. Endotoxin Res. 2002, 8:371-379.
49. Salomão R., Martins P.S., Brunialti M.K., Fernandes, Mda L., Martos L.S., Mendes M.E., Gomes N.E., Rigato O. TLR signaling pathway in patients with sepsis. Shock 2008, 73-77. (Suppl.).
50. Tominaga K., Saito S., Matsuura M., Nakano M. Lipopolysaccharide tolerance in murine peritoneal macrophages induces downregulation of the lipopolysaccharide signal transduction pathway through mitogen-activated protein kinase and nuclear factor-kappaB cascades, but not lipopolysaccharide-incorporation steps. Biochim. Biophys. Acta 1999, 1450:130-144.
51. Wolk K., Döcke W.D., von Baehr V., Volk H.D., Sabat R. Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood 2000, 96:218-223.
52. Yamasaki S., Ishikawa E., Sakuma M., Hara H., Ogata K., Saito T. Mincle is an ITAM-coupled activating receptor that senses damaged cells. Nat. Immunol. 2008, 9:1179-1188.
53. Zhang X., Morrison D.C. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peritoneal macrophages. J. Leukoc. Biol. 1993, 54:444-450.
54. Ziegler-Heitbrock L. The p50-homodimer mechanism in tolerance to LPS. J. Endotoxin Res. 2001, 7:219-222.